Psychiatry - December 2008 - (Page 39)

2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. S/2008/NEW01788.html. Access date: November 6, 2008. US Food and Drug Administration. Information for Healthcare Professionals Suicidality and Antiepileptic Drugs. http://www.fda.gov/Cder/Drug/Info Sheets/HCP/antiepilepticsHCP.htm. Access date: November 6, 2008. Summary Minutes. FDA Advisory Committee Meeting, 13 June 2007, FDA. US Food and Drug Administration. Antidepressant Use in Children, Adolescents, and Adults. http://www.fda.gov/cder/drug/antid epressants/default.htm. Access date: November 6, 2008. Freis ED. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med. 1954;251:1006–1008. Pies R. Persistent bipolar illness after steroid administration. Arch Intern Med. 1981;141:1087. Yourlawyer.com. Injured by Cymbalta? http://www.yourlawyer.com/topics/ overview/cymbalta. Access date: November 6, 2008. Papakostas GI. Tolerability of modern antidepressants. J Clin Psychiatry. 2008;69 Suppl E1:8–13. Meyer JM. Antipsychotic safety and efficacy concerns. J Clin Psychiatry. 2007; 68 [Suppl] 14:20–26. Marken P, Pies R. Emerging treatments for bipolar disorder: safety and side effect profiles. Ann Pharmacother. 2006;40:276–285. Mojtabai R, Olfson M. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the National Comorbidity survey Replication. J Clin Psychiatry. 2008;69:1064–1074. Ried LD, McFarland BH, Johnson RE, et al. Beta-blockers and depression: the more the murkier? Ann Pharmacother. 1998;32:699–708. Steffensmeier JJ, Ernst ME, Kelly M, et al. Do randomized controlled trials always trump case reports? A 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. second look at propranolol and depression. Pharmacotherapy. 2006;26:162–167. Pharmacovigilence. Naranjo’s algorithm. http://www.pharmacovigilance.co.in /casualityassesment.html. Access date: November 6, 2008. Dhondt ADF. Iatrogenic Origins of Depression in the Elderly. Proefschrift, Amsterdam: Vrije Universiteit, 2003. Thiessen BQ,Wallace SM, Blackburn JL, et al. Increased prescribing of anti-depressants subsequent to beta-blocker therapy. Arch Int Med. 1990;150:2286–2290. Nash MC. Substance-induced mood disorders: depression and mania. emedicine. Article Last Updated: Jul 23, 2008 www.emedicine.com/med/byname/s ubstance-induced-mood-disorderwith-depressive-features.htm. Access date: July, 2008. Maricle RA, Kinzie JD, Lewinsohn P. Medication-associated depression: a two and one-half year follow-up of a community sample. Int J Psychiatry Med. 1988;18:283–292. Turner E: Drug-induced depression [undated lecture]. http://www.fda.gov/ohrms/dockets/ ac/00/slides/3639s2b.pdf. Accessed date: August 7, 2008. Dhondt TD, Beekman AT, Deeg DJ, et al. Iatrogenic depression in the elderly. Results from a communitybased study in the Netherlands. Soc Psychiatry Psychiatr Epidemiol. 2002;37:393–398. Natarajan S, Lipsitz SR, Rimm E. A simple method of determining confidence intervals for population attributable risk from complex surveys. Stat Med. 2007;26:3229–3239. Baumeister AA, Hawkins MF, Uzelac SM. The myth of reserpineinduced depression: role in the historical development of the monoamine hypothesis. J Hist Neurosci. 2003;12:207–220. Broderick PA. Alprazolam, diazepam, yohimbine, clonidine: in-vivo CA1 hippocampal [VOLUME 5, 24. 25. 26. 27. 28. 29. 30. 31. 32. norepinephrine and serotonin release profiles under chloral hydrate anesthesia. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:1117–1140. Kreider ML, Tate CA, Cousins MM, et al. Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity. Neuropsychopharmacology. 2006;31:12–35. Pumariega AJ, Nelson R, Rotenberg L. Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS Spectr. 2008;13(6):511–514. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOPHypertension). Lancet. 1991;338:1281–1285. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280:623–629. Sokolski KN, Conney JC, Brown BJ, DeMet EM. Once-daily highdose pindolol for SSRI-refractory depression. Psychiatry Res. 2004;125(2):81–86. Waal HJ. Propranolol-induced depression. Br Med J. 1967;2(5543):50. Fitzgerald JD. Propranolol-induced depression. Br Med J. 1967;2(5548):372–373. Nemeroff C, Evans DL. Concurrent use of antidepressants and propranolol: case report and theoretical considerations. Biol 12, DECEMBER] NUMBER Psychiatry 2008 39 http://www.fda.gov/bbs/topics/NEWS/2008/NEW01788.html http://www.pharmacovigilance.co.in/casualityassesment.html http://www.pharmacovigilance.co.in/casualityassesment.html http://www.fda.gov/Cder/Drug/InfoSheets/HCP/antiepilepticsHCP.htm http://www.fda.gov/Cder/Drug/InfoSheets/HCP/antiepilepticsHCP.htm http://www.fda.gov/cder/drug/antidepressants/default.htm http://www.fda.gov/cder/drug/antidepressants/default.htm http://www.emedicine.com/med/byname/substance-induced-mood-disorder-with-depressive-features.htm http://www.emedicine.com/med/byname/substance-induced-mood-disorder-with-depressive-features.htm http://www.emedicine.com/med/byname/substance-induced-mood-disorder-with-depressive-features.htm http://www.Yourlawyer.com http://www.yourlawyer.com/topics/overview/cymbalta http://www.yourlawyer.com/topics/overview/cymbalta http://www.fda.gov/ohrms/dockets/ac/00/slides/3639s2b.pdf http://www.fda.gov/ohrms/dockets/ac/00/slides/3639s2b.pdf

Table of Contents Feed for the Digital Edition of Psychiatry - December 2008

Psychiatry - December 2008 Editor’s Message Contents Editorial Advisory Board Antidepressant Prescribing by Specialty and Treatment of Premenstrual Dysmorphic Disorder Pain, Pain, Go Away: Antidepressants and Pain Management Why Psychotherapy Helps the Patient in Chronic Pain General Medical Drugs Associated with Depression Katatonia: A New Conceptual Understanding of Catatonia and a New Rating Scale Thermoregulation and the Role of Calcium Signalling in Neurotransmission Cognition and Schizophrenia: Is There a Role for Cognitive Assessments in Diagnosis and Treatment? Journal Watch Information for Authors

Psychiatry - December 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.